Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000893838-07-000012
Filing Date
2007-01-08
Accepted
2007-01-08 16:23:05
Documents
1
Period of Report
2006-12-11

Document Format Files

Seq Description Document Type Size
1 form4parkjan07_ex.html 4  
1 form4parkjan07_ex.xml 4 11964
  Complete submission text file 0000893838-07-000012.txt   13845
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address (240) 268-5300
Park Young Soon (Reporting) CIK: 0001316422 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50590 | Film No.: 07517849